Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
about
Respirable antisense oligonucleotides: a new drug class for respiratory diseaseMicroRNA Regulation of Human Breast Cancer Stem CellsProgress and Prospects of Anti-HBV Gene Therapy DevelopmentApproved Antiviral Drugs over the Past 50 YearsHitting bacteria at the heart of the central dogma: sequence-specific inhibitionDetermination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerOcular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theRecent strategies in the development of new human cytomegalovirus inhibitors.Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy.Oligonucleotide delivery: a patent review (2010 - 2013).2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.Bioanalysis of siRNA and oligonucleotide therapeutics in biological fluids and tissues.The search for new therapies for human cytomegalovirus infections.Advances in targeted therapeutic agents.Design and development of antisense drugs.Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.Resisting resistance: is there a solution for malaria?(Non-)translational medicine: targeting bacterial RNAAntisense oligodeoxynucleotides targeted against molecular chaperonin Hsp60 block human hepatitis B virus replication.2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.The birth of ocular pharmacology in the 20th century.Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.Alternative Splicing as a Target for Cancer Treatment.Desulfurization of aromatic polysulfides with triphenylphosphine
P2860
Q24791659-C6AF412B-8311-41B5-BA58-C4C310658A6FQ26771792-F27D6990-C896-4F06-A94F-37582F3F68AAQ26799228-9F186201-E47B-4963-B9CE-92D5BA034A64Q27755387-98BD7765-1505-4971-8F69-25B8777B6645Q28756986-44369172-2634-4071-AD81-6497483D29B4Q30704352-E8C54274-2E96-415A-8E4E-93C10FED48E4Q33650105-C623DF6B-7243-4453-91E3-21868ABA5BF1Q34011377-530373B6-8C78-4CD8-B275-9405BA1CB603Q34212799-0FC80758-45C7-4B16-A866-CB1A8EF17326Q34218241-C942022F-6219-4416-9CDA-79D2BA9BEF57Q34911031-9C9771A8-5B1E-4F6E-A2E5-3818AC9DFFDDQ35163373-20BF3565-BA24-439B-A833-8AFF71DC9BE1Q35614631-4F93DDC8-4B94-4B8F-A978-29A8BB7376C4Q36673652-5CBB5C85-331C-4581-B617-94630A25AA5AQ37477905-23AEFB8E-24D3-49E8-A9B0-755CA41A2BBFQ37810190-A1D51E31-E420-4B02-B760-5B113C6467D0Q37811458-82B866FD-7C88-485C-B82C-4CD99B4B39A5Q38029122-CA7008E1-2050-47CA-B8A1-4BFD3F551E6BQ38089175-3D94966E-5E6F-4114-BD59-2790F518F1E2Q38346533-8E8114F8-22CF-4BAF-8EA9-13A48A797AD1Q38755043-A2F11D4B-AE50-4788-9742-676A9ECA9CC1Q42276515-4D6DB9C9-37FD-4A6F-B2E8-9D217AB5FE63Q44517517-361EE27A-01F5-416E-BA11-437AF31FE7E9Q44616568-D1DC35EF-050C-491D-918A-B9A81958EBBAQ44875663-6038AA8B-C534-46EB-9236-0E27C42E36C8Q48648024-C1695F59-0683-44BC-A081-2253FB257C2DQ50033988-91615C2F-7F03-4620-93A9-F942C056C89FQ57086085-9DF06500-C18E-4357-9581-3036767F42F2
P2860
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@ast
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@en
type
label
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@ast
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@en
prefLabel
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@ast
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@en
P2093
P2860
P1476
Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis.
@en
P2093
Meenken CJ
de Smet MD
van den Horn GJ
P2860
P304
P356
10.1076/OCII.7.3.189.4007
P577
1999-12-01T00:00:00Z